Sponsor pipeline

Blekinge Institute of Technology clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Not charted: 8 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Not applicable
NCT07166224	The Effect of Regular Home Use of Dual-light Antibacterial Photodynamic Therapy (aPDT) or…	Periodontal Diseases	Recruiting	2026-10-01
NCT07263399	Effect of Hydrogen Gas on Hyperbaric Oxygen Toxicity	Oxygen Toxicity	Not Yet Recruiting	2025-12-04
NCT07001514	Evening Screen Content and Sleep Architecture in Older Adults: Crossover RCT	Sleep	Not Yet Recruiting	2025-06-03
Not specified
NCT06337201	A Digital Life Story to Support Person-centred Care for Older Adults With Dementia…	Cognitive Impairment	Recruiting	2024-03-29
NCT07201610	Non-invasive Diagnosis of Parkinson's Disease	Parkinsons Disease (PD)	Not Yet Recruiting	2025-10-01
NCT06981286	Oral Health Parameter-Based Diabetes Type 2 Indication Using Machine Learning	Type 2 Diabetes	Not Yet Recruiting	2025-05-20
NCT06705647	Analyzing Acoustic Properties of the Vowel "a" Collected Via Mobile Phone From…	Chronic Obstructive Pulmonary Disease	Active, Not Recruiting	2024-11-26
NCT06160674	Vowel Segmentation for Classification of Chronic Obstructive Pulmonary Disease Using…	Chronic Obstructive Pulmonary Disease	Active, Not Recruiting	2024-11-25

Get alerts when Blekinge Institute of Technology's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.